Cord Serum Inflammatory Cytokines as Biomarkers of Cerebral Palsy
نویسندگان
چکیده
منابع مشابه
Therapeutic Potency of Cord Blood Stem Cells in Patients with Cerebral Palsy: A Systemic Literature Review
Background: The main objective of this study was to systematically review the reported potency of cord blood stem cells in treating patients with neurological disorders such as cerebral palsy. Methods: PubMed, Scopus, and Cochrane were searched thoroughly on September 2016 using the following search terms: “Umbilical cord blood stem cells” AND “development” AND “cerebral palsy” to find articl...
متن کاملCytokines and Chemokines as Biomarkers of Tuberculosis
Tuberculosis (TB) is an old disease representing a major public health problem globally. The current widely used tools are very long time since licensed and are inefficient in diagnosing and prognosing of tuberculosis infection and disease. A new diagnostic test which is sensitive, specific and rapid is urgently needed for timely detection, appropriated treatment response and control. Biomarker...
متن کاملP168: Delayed Imatinib Treatment for Spinal Cord Damage; Role of Serum Biomarkers and Recovery
With no routine accessible medicine intervention for spinal cord damage, there is a demand for more remedial candidates. However, for Imatinib to have translational price, it requires to have encouraged obliging effects with delayed start of treatment, as well. Serum levels of 3 chemokines/ cytokines, MIP-3α, MCP-1, and GRO/ KC (IL-8), to raise over time with Imatinib treatment and to be ...
متن کاملNeonatal signs as predictors of cerebral palsy.
Signs of neonatal neurologic dysfunction, recorded in approximately 40,000 infants, were evaluated prospectively for their ability to predict later motor handicap. Tenfold to 33-fold increases in risk of cerebral palsy (CP) were observed in surviving children with any one of the following characteristics: birth weight less than 2,000 gm, head circumference more than 3 SD above or below the mean...
متن کاملCytokines as Biomarkers in Rheumatoid Arthritis
RA is a complex disease that develops as a series of events often referred to as disease continuum. RA would benefit from novel biomarker development for diagnosis where new biomarkers are still needed (even if progresses have been made with the inclusion of ACPA into the ACR/EULAR 2010 diagnostic criteria) and for prognostic notably in at risk of evolution patients with autoantibody-positive a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Neurology Briefs
سال: 2004
ISSN: 2166-6482,1043-3155
DOI: 10.15844/pedneurbriefs-18-2-4